Chambers Review
Provided by Chambers

Band 4
Band 4
Provided by Eduardo Hallak
Litigation
Regulatory
Patents
Trademarks
Antitrust & Competition
Copyright & Software
Plant Variety Protection
Life Sciences
Eduardo Hallak is a founding partner at Licks Attorneys and leads the firm’s Sao Paulo office. With over a decade of experience, he has established himself as a prominent litigator in complex disputes and leading cases in Brazil.
Mr. Hallak specializes in litigation involving patent law, competition, and regulatory compliance, with a particular focus on the life sciences sector. He also has extensive experience in trademark litigation and technology transfer contracts, assisting multinational clients in establishing robust brand protection and licensing programs in Brazil.
As an educator, Mr. Hallak serves as a professor of IP litigation in the post-graduate program at the prestigious Pontifical Catholic University of Rio de Janeiro (PUC-Rio) and has taught Civil Procedure at the Brazilian Association of IP Agents (ABAPI). A frequent speaker on procedural and strategic aspects of IP litigation, he also serves as a member of the Special Commission on Mediation of the Rio de Janeiro Chapter of the Brazilian Bar Association (OAB-RJ) and the Enforcement Committee of the International Trademark Association (INTA).
Mr. Hallak's excellence is consistently recognized by esteemed publications, including Chambers and Partners, The Legal 500, and Who’s Who Legal . Client testimonials praise him for having “in-depth legal technical skills, but also knowing very well how the business works”, as well as for “his contentious expertise that makes him a regular port of call for transactional advice keyed to potential industry conflicts”.
Brazilian Bar Association;
Brazilian Intellectual Property Association;
American Intellectual Property Law Association;
Pharmaceutical Trade Marks Group;
International Trademark Association.
AIPPI (Association Internationale pour la Protection de la Proprieté Intellectuelle)
Trends and Developments - Life Sciences & Pharma IP Litigation 2025, Chambers, 2025;
Cenário de inovação no Brasil: Uma breve análise, Migalhas, 2024;
CRISPR-CAS-based inventions: Advantages for agriculture and an overview of patent protection in Brazil, Lexology, 2024;
Novidades do regulamento das PDPs são mesmo novidades? – Parte 1, JOTA, 2024;
New PDP Regulation: Fresh Start or Same Old thing? – Part 1, Lexology, 2024;
Mais um passo para a retomada das PDPs: a minuta de norma resolve os erros do passado?, JOTA, 2023;
Another step towards the return of PDPs: does the draft new regulation solve past mistakes?, Lexology, 2023;
Notas sobre a Lei de Biossegurança à luz da ADI 3526, JOTA, 2023;
Julgamento da lei de patentes no STF é de ‘extrema preocupação’ para inovação do agro, Canal Rural, 2021;
HALLAK, Eduardo. Direito Processual da Propriedade Intelectual. São Paulo: Editora Revista dos Tribunais - Thomson Reuters, 2023;
Brazilian Courts: ANVISA Must Apply Federal Law or Face Bad Faith Litigation, Food and Drug Law Institute (FDLI), 2015;
Ambush Marketing and Sport Events, Visão Jurídica, 2013;
Data Package Protection in Brazil, World Intellectual Property Review, 2011;
Medicine Packaging and Copyrights, World Intellectual Property Review, 2010.
Litigation
Government Affairs & International Relations
Regulatory
Patents
Trademarks
Antitrust & Competition
Copyright & Software
Plant Variety Protection
Life Sciences
Eduardo Hallak is a founding partner at Licks Attorneys and leads the firm’s Sao Paulo office. With over a decade of experience, he has established himself as a prominent litigator in complex disputes and leading cases in Brazil.
Mr. Hallak specializes in litigation involving patent law, competition, and regulatory compliance, with a particular focus on the life sciences sector. He also has extensive experience in trademark litigation and technology transfer contracts, assisting multinational clients in establishing robust brand protection and licensing programs in Brazil.
As an educator, Mr. Hallak serves as a professor of IP litigation in the post-graduate program at the prestigious Pontifical Catholic University of Rio de Janeiro (PUC-Rio) and has taught Civil Procedure at the Brazilian Association of IP Agents (ABAPI). A frequent speaker on procedural and strategic aspects of IP litigation, he also serves as a member of the Special Commission on Mediation of the Rio de Janeiro Chapter of the Brazilian Bar Association (OAB-RJ) and the Enforcement Committee of the International Trademark Association (INTA).
Mr. Hallak's excellence is consistently recognized by esteemed publications, including Chambers and Partners, The Legal 500, and Lexology Index. Client testimonials praise him for having “in-depth legal technical skills, but also knowing very well how the business works”, as well as for “his contentious expertise that makes him a regular port of call for transactional advice keyed to potential industry conflicts”.
Brazilian Bar Association – Rio de Janeiro (OAB/RJ);
Brazilian Intellectual Property Association (ABPI);
American Intellectual Property Law Association (AIPLA);
Pharmaceutical Trade Marks Group (PTMG);
International Trademark Association (INTA).
Trends and Developments - Life Sciences & Pharma IP Litigation 2025, Chambers, 2025;
Cenário de inovação no Brasil: Uma breve análise, Migalhas, 2024;
CRISPR-CAS-based inventions: Advantages for agriculture and an overview of patent protection in Brazil, Lexology, 2024;
Novidades do regulamento das PDPs são mesmo novidades? – Parte 1, JOTA, 2024;
New PDP Regulation: Fresh Start or Same Old thing? – Part 1, Lexology, 2024;
Mais um passo para a retomada das PDPs: a minuta de norma resolve os erros do passado?, JOTA, 2023;
Another step towards the return of PDPs: does the draft new regulation solve past mistakes?, Lexology, 2023;
Notas sobre a Lei de Biossegurança à luz da ADI 3526, JOTA, 2023;
Direito Processual da Propriedade Intelectual. São Paulo: Editora Revista dos Tribunais – Thomson Reuters, 2023;
Julgamento da lei de patentes no STF é de ‘extrema preocupação’ para inovação do agro, Canal Rural, 2021;
Brazilian Courts: ANVISA Must Apply Federal Law or Face Bad Faith Litigation, Food and Drug Law Institute (FDLI), 2015;
Ambush Marketing and Sport Events, Visão Jurídica, 2013;
Data Package Protection in Brazil, World Intellectual Property Review, 2011;
Medicine Packaging and Copyrights, World Intellectual Property Review – WIPR, 2010.
Provided by Chambers








Provided by Chambers
Eduardo Hallak is a lawyer with deep industry knowledge.
An exceptionally professional lawyer, Eduardo Hallak consistently provides clear, strategic advice tailored to the specific needs of each matter.
Eduardo Hallak is a lawyer with deep industry knowledge.
An exceptionally professional lawyer, Eduardo Hallak consistently provides clear, strategic advice tailored to the specific needs of each matter.
2 items provided by Licks Attorneys
Compulsory Licensing in Brazil (2026): The Mounjaro Case
In the first quarter of 2026, and particularly over the past few weeks, compulsory licensing has re-emerged as a recurring legislative theme in Brazilian Congress.
The Right to in-kind compensation due to unjustified administrative delay
The article examines the right to in-kind compensation arising from unjustified administrative delays in patent grant proceedings, discussing the State’s civil liability in such cases and the resulting impacts on intellectual property right holders.
Compulsory Licensing in Brazil (2026): The Mounjaro Case
In the first quarter of 2026, and particularly over the past few weeks, compulsory licensing has re-emerged as a recurring legislative theme in Brazilian Congress.
The Right to in-kind compensation due to unjustified administrative delay
The article examines the right to in-kind compensation arising from unjustified administrative delays in patent grant proceedings, discussing the State’s civil liability in such cases and the resulting impacts on intellectual property right holders.